A spate of congressional hearings this week will examine the opioid crisis, as lawmakers work to craft bipartisan legislation before the Memorial Day recess.

Four hearings on May 8 will focus on opioids:

Meanwhile, the Energy and Commerce Committee on May 9 will hold the first of two full committee mark-up sessions on its opioid-related legislative package; the second mark-up is scheduled for May 17.

340B Hearing

The Senate Committee on Health, Education, Labor, and Pensions will hold a May 15 hearing focused on oversight reports on the 340B Drug Pricing Program. Witnesses for the hearing include Ann Maxwell, assistant inspector general for evaluation and inspections at the Department of Health and Human Services’ Office of the Inspector General, and Debra Draper, director of the health care team at the Government Accountability Office.

Other Committee Activity

The House Committee on Ways and Means will hold a May 9 hearing on Medicare Advantage.